Impact at a Glance

• Alkem Foundation and IIT Bombay announced a strategic collaboration to establish the “Alkem Centre for Advanced Research and Development of Applied Immuno-Therapeutics and Regenerative Medicines” at IIT Bombay.
• The Centre represents a pioneering CSR-led effort to advance research and innovation in complex disease areas with significant unmet medical needs.
• Alkem Foundation will contribute 20–25% of its cumulative CSR obligations over seven years toward establishing this research centre, which will continue under the “Alkem” name in perpetuity.
• This is the first industry–academia collaboration in India, initiated through the CSR route, focused on immuno-therapeutics and regenerative medicines.
• The partnership combines Alkem’s pharmaceutical expertise with IIT Bombay’s strengths in biomedical engineering, research capabilities, and globally trained faculty to create a distinctive innovation ecosystem.
• The Centre aims to build a comprehensive ecosystem enabling innovation, research, and skill development in complex and underserved therapy areas.
• It seeks to bridge critical gaps in infrastructure, talent, and translational capabilities, particularly in high-precision medicines.
• The Centre will include mentors from IIT Bombay and Alkem, along with global experts from premier universities who will advise on research programmes.

Leadership Insight

“IIT Bombay is committed to pushing the frontiers in biomedical research, and we are delighted to partner with Alkem Foundation as it provides a great opportunity to combine academic excellence with industry expertise. This collaboration will enable progressive work in immuno-therapeutics and regenerative medicines and provide impetus to indigenous R&D and manufacturing, thereby reducing reliance on expensive imported therapies.”

— Prof. Shireesh B. Kedare, Director, IIT Bombay

Strategic Alignment: Advancing Precision Healthcare Through Purpose-Driven Collaboration

The establishment of the Alkem Centre at IIT Bombay marks a significant step in leveraging CSR to strengthen India’s capabilities in immuno-therapeutics and regenerative medicines. By combining Alkem Foundation’s industry insight with IIT Bombay’s deep research expertise, the collaboration creates a robust foundation for innovation, talent development, and translational impact in high-need therapy areas. This partnership underscores how focused CSR investments can accelerate scientific progress and contribute to India’s long-term leadership in advanced healthcare research.

Image sources: IITB FB – Alkem